Corpus ID: 40756821

Folic acid alters methotrexate availability in patients with rheumatoid arthritis.

@article{Bressolle2000FolicAA,
  title={Folic acid alters methotrexate availability in patients with rheumatoid arthritis.},
  author={F. Bressolle and J. M. Kinowski and J. Morel and B. Pouly and J. Sany and B. Combe},
  journal={The Journal of rheumatology},
  year={2000},
  volume={27 9},
  pages={
          2110-4
        }
}
  • F. Bressolle, J. M. Kinowski, +3 authors B. Combe
  • Published 2000
  • Medicine
  • The Journal of rheumatology
  • OBJECTIVE To evaluate the effects of repeated doses of folic acid on the pharmacokinetics of methotrexate (MTX) in patients with rheumatoid arthritis. METHODS We studied 20 patients (ages 30-78 years) who received MTX intramuscularly (10 mm/week). MTX was administered alone or after treatment with folic acid (5 mg tablet once daily) for 13 days. Plasma samples were collected 2 and 8 h after dose intake. MTX concentrations in plasma and ultrafiltrate samples were measured by fluorescence… CONTINUE READING

    Topics from this paper.

    Folate supplementation during methotrexate therapy for rheumatoid arthritis.
    • 41